Afuco™ Anti-IL6 ADCC Therapeutic Antibody (Sirukumab), ADCC Enhanced

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to IL6. Sirukumab (CNTO 136) is a human monoclonal antibody designed for the treatment of rheumatoid arthritis.
Supplier Creative Biolabs
Product # AFC-TAB-097
Pricing Inquiry
Host Human
Target IL6
Species Reactivity Human
Type ADCC enhanced antibody
Applications FC, IP, ELISA, Neut, FuncS, IF
Storage Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback